Results
1 -
10 of
90Pharmacology, Clinical Efficacy, and Tolerability of Phosphodiesterase-4 Inhibitors: Impact of Human Pharmacokinetics, Phosphodiesterases as Drug Targets Research Pipeline II: Oral Therapeutics, Advances in Psoriasis Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions, Biologic and Systemic Agents in Dermatology Immunosuppressants, Pruritus 69-Year-Old with Psoriasis and a History of Skin Cancer, Clinical Cases in Psoriasis Topical and Systemic Therapies for Moderate-to-Severe Psoriasis, Psoriatic Arthritis and Psoriasis Combining Phototherapy with Apremilast, Clinical Cases in Phototherapy Oral Non-biologic Therapies and Non-pharmacological Therapies in PsA, Psoriatic Arthritis and Psoriasis HIV Infection in a 44-Year-Old with Psoriasis, Clinical Cases in Psoriasis